1. Introduction {#sec1}
===============

The concept of "minimally invasive surgery" (MIS) continues to attract the attention of patients and surgeons. The potential to obtain the full benefits of surgical treatment with less morbidity is a universal goal. While long-term patient reported outcomes and reoperation rates may be the ultimate measure of success, perioperative metrics such as length of surgery and blood loss can further our understanding of "invasiveness." Additionally, shorter operative times and less blood loss can translate into cost-savings, which are of utmost importance in the current social-medical climate (see Figs. [1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}).Fig. 165yo with a mobile Degenerative Spondylolisthesis with Lumbar Spinal Stenosis and Neurogenic Claudication. Pre-op ODI = 38, Back pain = 7, andLeg pain = 5.Fig. 1Fig. 2Post-operative MidLIF with ODI = 9, Back pain = 0, and Leg pain = 0. Notice the medial to lateral Cortical Bone Screw (CBT) trajectory and the avoidance of the supra-adjacent facet.Fig. 2

Previous studies on tubular MIS transforaminal interbody fusion (TLIF) have used estimated blood loss (EBL) as a marker of invasiveness [@bib1]. Surgical blood loss has been associated with increased surgical risks including infection and other complications [@bib2]. Costs associated with surgical blood loss include cell saver costs and allogenic transfusion \[[@bib3], [@bib4]\]. Recent meta-analyses have shown that tubular MIS TLIF is associated with lower blood loss compared to open TLIF \[[@bib5], [@bib6], [@bib7], [@bib8], [@bib9]\].

Operative time is associated with direct costs including personnel and operating room costs. The charge for 1 h of operating room time (excluding physician time) has been reported to be \$3720 or more \[[@bib10], [@bib11]\]. Recent meta-analyses have shown that operative time for tubular MIS TLIF is not significantly different from open TLIF \[[@bib5], [@bib7], [@bib8], [@bib9]\], with one meta-analysis showing increased operative time for MIS TLIF [@bib6].

The purpose of the current study is to quantify the "invasiveness" of a newer technique for posterior decompression and interbody fusion with limited midline exposure. The technique relies on the cortical bone trajectory for pedicle fixation, which does not require exposure lateral to the facet and avoids the additional dissection required to expose the transverse processes. The decompression and interbody fusion can be performed via the familiar midline exposure which greatly diminishes the learning curve. The study authors believe that this technique has been a substantial advancement in their clinical practice with significant improvements in EBL, operative time, length of stay, and patient reported outcomes (PROs) compared to their previous experience with traditional open TLIF. We hypothesized that a single-surgeon consecutive series would show these significant improvements and compare well with literature controls for tubular MIS TLIF.

2. Methods {#sec2}
==========

A consecutive single-surgeon series of patients who underwent posterior interbody fusion from December 2014 to December 2016, during the transition from full, traditional open exposure of the transverse processes with freehand pedicle screws (open TLIF) to a navigated, limited midline exposure (MidLIF) with cortical bone trajectory screws, were identified. Demographic, peri-operative, and patient reported outcome data were collected and compared.

2.1. MidLIF surgical technique {#sec2.1}
------------------------------

A standard midline incision and subperiosteal dissection is made out to the lateral portion of the facet joint. A self-retaining retractor is placed and maintained until time of closure. A navigation frame is mounted to a spinous process clamp on the cranial end of the incision. Using intra-operative computed tomography based navigation instruments, screw paths are prepared using a cortical bone trajectory (inferior to superior, medial to lateral) through the pedicle. Care is taken to avoid impingement on the supra-adjacent facet. Decompression of the spinal stenosis and interbody fusion is then preformed using standard techniques. Remaining facets joints are decorticated and bone graft is placed. The self-retaining retractor is removed and the wound closed in standard fashion, typically without drains.

2.2. Traditional open TLIF surgical technique {#sec2.2}
---------------------------------------------

A standard midline incision and subperiosteal dissection is made out to the tips of the transverse processes which elevates and detaches the longissimus and multifidus from the posterolateral gutter. Retractors typically are placed, but must be moved and adjusted to allow for the lateral to medial trajectory of traditional pedicle screws using a standard, "free-hand" technique. The decompression and interbody fusion then proceeds in standard fashion. Prior to closure, decortication and bone grafting of remaining facets and the transverse processes (lateral gutters) is performed.

This study was reviewed and approved by the University of Louisville Institutional Review Board.

3. Results {#sec3}
==========

The two groups had similar demographics ([Table 1](#tbl1){ref-type="table"}) and number of surgical levels ([Table 2](#tbl2){ref-type="table"}). All surgeries were primary (non-revision) fusions of the index level. Surgical indications were similar between groups and included mobile spondylolisthesis and foraminal stenosis which required facet resection and/or elevation of foraminal height for adequate decompression.Table 1Summary of demographic parameters.Table 1MidLIFOpen TLIFp-valueN2927Males, N790.647Age, years, mean (SD)61.66 (7.81)58.26 (9.94)0.164BMI, kg/m [@bib2], mean (SD)34.79 (5.94)34.66 (7.67)0.943ASA Grade, N2350.37532621401Table 2Summary of surgical parameters.Table 2MidLIFOpen TLIFp-valueN2927Estimated Blood Loss, cc, mean (SD)266.38 (129.09)446.11 (261.88)0.003Cell SaverPatients infused9160.060Volume infused42.41 (64.40)133.15 (152.67)0.007Operative Time, min, mean (SD)170.10 (36.51)209.92 (53.65)0.003No of Surgical Levels, N0.97812322255No of Interbody Fusions, N0.76012625232Length of Hospital Stay2.90 (1.24)3.70 (1.20)0.016

Estimated blood loss was significantly less in the MidLIF group (266 vs. 446 mL, p = 0.003). Consistent with lower EBL in the MidLIF group, cell saver volume infused was significantly less in the MidLIF group (42 vs. 133 mL, p = 0.007). Surgical time (170 vs. 210 minutes, p = 0.003) and length of hospital stay was significantly less in the MidLIF group (2.9 vs. 3.7 days, p = 0.016).

A sub-group analysis of single level cases ([Table 3](#tbl3){ref-type="table"}) showed similar results with less EBL (247 vs. 411 mL, p = 0.010), surgical time (159 vs. 199 minutes, p = 0.003), and hospital stay (2.9 vs. 3.6 days, p = 0.023) in the minimally invasive, MidLIF group.Table 3Sub-analysis of single level cases.Table 3MidLIFOpen TLIFp-valueN2322Age, years, mean60.04 (7.59)58.45 (9.10)0.529BMI, kg/m [@bib2], mean34.76 (6.11)35.67 (7.09)0.647Males580.279ASAGrade0.38223532016401Estimated Blood Loss, cc, mean (SD)247 (127.10)411 (252.40)0.010Operative Time, min, mean (SD)159 (28.32)199 (50.74)0.003Length of Hospital Stay2.91 (1.16)3.64 (1.29)0.023

Patient reported outcomes (PROs) at baseline, 6 weeks, 3 months, 6 months, 12 months and 24 months are shown in [Table 4](#tbl4){ref-type="table"}. Pre-operative PROs showed a slightly lower baseline Back Pain in the MidLIF group (6.3 vs. 7.7, p = 0.003). Six week PROs showed greater ODI improvement in the MidLIF group (23 vs. 7, p = 0.008). Twelve-month PROs favored MidLIF with lower ODI (less lumbar disability) (26.7 vs. 43.1, p = 0.009), more improvement in ODI (23.1 vs. 7.3, p = 0.018) and less Back Pain (2.45 vs. 5.14, p = 0.002). Twenty-four month PROs also favored MidLIF with lower ODI (less lumbar disability) (26.9 vs. 47.1, p = 0.015) and less Back Pain (2.79 vs. 5.54, p = 0.019) compared to the open TLIF group.Table 4Patient Reported Outcomes for patients with 12 month and 24 month follow-up.Table 4MidLIFOpen TLIFp-valueN2927N Baseline PROs2824MeanSDMeanSDp-valueBaseline ODI48.1116.2854.0318.860.239Baseline BP6.301.517.671.630.003Baseline LP6.142.457.212.230.106Baseline EQ5D0.560.210.460.250.247N 6 week PROs2818MeanSDMeanSDp-value6 week ODI26.8218.4542.4518.326 week BP2.452.233.802.380.0526 week LP1.552.012.652.250.0886 week EQ5D0.760.170.660.160.132Change_6w_ODI22.8518.206.6618.980.008Change_6w_BP3.782.333.332.910.591Change_6w_LP4.712.613.943.670.446Change_6w_EQ5D0.240.250.280.160.612N 3 month PROs2421MeanSDMeanSDp-value3 month ODI26.2317.9440.6821.313 month BP2.852.513.872.740.1803 month LP2.332.593.173.080.3073 month EQ5D0.710.220.600.250.178Change_3m_ODI24.6322.8613.2320.230.083Change_3m_BP3.402.903.433.060.974Change_3m_LP3.693.753.623.440.945Change_3m_EQ5D0.160.280.240.230.509N 6 month PROs1916MeanSDMeanSDp-value6 month ODI27.1517.2643.1822.606 month BP3.152.113.892.520.3376 month LP2.453.273.172.640.4606 month EQ5D0.720.230.570.230.143Change_6m_ODI22.3221.009.0023.460.096Change_6m_BP3.052.503.003.060.956Change_6m_LP4.113.893.252.840.458Change_6m_EQ5D0.130.210.150.160.898N 12 month PROs2022MeanSDMeanSDp-value12 month ODI26.6521.5943.1416.420.00912 month BP2.452.505.142.610.00212 month LP2.752.854.232.860.10212 month EQ5D0.720.220.560.240.158Change_12m_ODI23.1122.517.2916.540.018Change_12m_BP3.612.812.352.540.157Change_12m_LP3.743.962.553.250.314Change_12m_EQ5D0.200.200.170.220.764N 24 month PROs1413MeanSDMeanSDp-value24 month ODI26.8621.2147.0819.060.01524 month BP2.792.865.542.820.01924 month LP3.233.424.622.660.26124 month EQ5D0.730.240.610.240.198Change_24m_EQ5D0.120.240.170.240.622Change_24m_ODI16.5021.984.8212.190.107Change_24m_BP3.293.021.362.540.098Change_24m_LP2.854.101.732.050.399[^1]

Readmissions and reoperations are reported in [Table 5](#tbl5){ref-type="table"}. Readmission rates (\<90 days) were not significantly different between groups. Late reoperations for symptomatic adjacent segment pathology (Adjacent Segment Disease) were significantly greater in the traditional open TLIF group (4/27 vs. 0/29, p = 0.048). Late reoperations for pseudoarthrosis were not significantly different between groups.Table 5Re-admissions and Re-operations.Table 5MIDLIF N = 29Open TLIF N = 27p-valueReadmission (\<90 days) Total250.244Readmission (\<90 days) for medical complication (chest pain)010.999Readmission (\<90 days) with reoperation for wound complication120.605Readmission (\<90 days) with reoperation for persistent radiculopathy111.000Late reoperation for Adjacent Segment Disease040.048Late reoperation for Pseudoarthrosis101.000

4. Discussion {#sec4}
=============

The "MidLIF" using a cortical bone trajectory for pedicle screw fixation is a modification of the traditional midline exposure used in the open TLIF technique. The difference with this "minimally invasive" modification is limiting the exposure just lateral edge of the facet. Avoiding exposure lateral to the facet avoids elevating the multifidus, avoids detaching the longissimus from the transverse process, and potentially spares the neurovascular bundle to the erector spinae muscles. The concept of the cortical bone trajectory has made pedicle screw fixation possible through this limited midline exposure. Because the technique is relatively new, significant questions still remain. One of these questions is the "invasiveness" of the surgery. "Invasiveness" can be measured in various ways. The purpose of the current study was to look at three commonly measured perioperative parameters (i.e. surgical time, blood loss, and length of hospital stay) and to compare the new technique to the traditional technique. Secondarily, by looking at the existing literature, we are able to establish reference standards for open TLIF and minimally invasive TLIF.

The current study was designed as a single-surgeon series to minimize the inherent variability from surgeon to surgeon in experience and surgical technique. The study was designed as a consecutive series to minimize selection bias, as well as, present a "worse case scenario" for the learning curve of the new technique. Additionally, the transition period between the old technique and the new technique minimizes any confounding changes that may evolve over time in a surgeon\'s practice.

The current literature contains extensive comparisons between traditional open TLIF and minimally invasive TLIF \[[@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib12], [@bib13], [@bib14]\]. The term "minimally invasive TLIF" is most commonly used to refer to a paramedian approach where a tubular retractor and "percutaneous" screws are used to accomplish the surgical goals of decompression and stabilization. The tubular MIS TLIF literature has matured to the point where systematic reviews and meta-analyses are possible \[[@bib5], [@bib6], [@bib7], [@bib8], [@bib9]\]. The majority of these recent meta-analyses have shown that there is no significant difference in surgical time between tubular MIS TLIF and Open TLIF \[[@bib5], [@bib7], [@bib8], [@bib9], [@bib12], [@bib13]\], with the exception of Hu [@bib6] et al that showed increased operative time for the MIS group. All of the meta-analyses have consistently shown that EBL is lower in MIS TLIF when compared to Open TLIF. The results of the current study compare favorably to this best-available evidence regarding MIS TLIF ([Table 6](#tbl6){ref-type="table"}). Also, the results compare favorably to a recent comparative study from the same institution as the current study [@bib15]. ([Table 6](#tbl6){ref-type="table"}).Table 6Current study data for single level MidLIF cases compares favorably to literature controls for tubular "minimally invasive surgery" (MIS) TLIF.Table 6Comparative study or meta-analysisEBL (cc), meanDifference favoring MIS (cc)Surgical time (min), meanDifference favoring MIS (min)MISOpenMISOpenCurrent (MidLIF)24741116415919940Djurasovic (Comparative MIS)262614352264279NSXie (Meta-analysis MIS)224506266195198NSHu (Meta-analysis MIS)267535268212190\*Goldstein (Meta-analysis MIS)NRNR260NRNRNSPhan (Meta-analysis MIS)177461256185186NSTian (Meta-analysis MIS)NRNR219NRNRNS[^2]

Limitations of the current study include the relatively small sample size and single surgeon series. Future studies with more patients and more surgeons are needed to determine if the same technique advantages are generalizable. Additionally, it is important to note that lack of formal posterolateral fusion (which is similar to the tubular TLIF techniques) likely requires successful interbody fusion for long-term success. Formal assessment of fusion was not possible in this series, as the majority of patients did not have postoperative computed tomography and plain radiographs are generally considered inadequate for fusion assessment. Although we did not see a significant difference in reoperation rates for pseudoarthrosis in this series, fusion success will depend on various patient specific and surgeon controlled variables that may become more apparent with additional experience and study.

The results of the study suggest that "minimally invasive" MidLIF compares favorably to open TLIF and MIS tubular TLIF with regards to EBL and surgical time. Importantly, patient reported outcomes and reoperation rates also favored MidLIF when compared to a traditional open TLIF technique. Future experience and study will ultimately determine if the procedure advantages are generalizable to a broader patient and surgeon population.

Declarations {#sec5}
============

Author contribution statement {#sec5.1}
-----------------------------

Charles H. Crawford III: Conceived and designed the experiments; Performed the experiments; Analyzed and interpreted the data; Contributed reagents, materials, analysis tools or data; Wrote the paper.

Roger K. Owens II, Mladen Djurasovic, Jeffrey L. Gum: Performed the experiments; Contributed reagents, materials, analysis tools or data; Wrote the paper.

John R. Dimar II: Performed the experiments; Contributed reagents, materials, analysis tools or data.

Leah Y. Carreon: Conceived and designed the experiments; Analyzed and interpreted the data; Contributed reagents, materials, analysis tools or data.

Funding statement {#sec5.2}
-----------------

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Competing interest statement {#sec5.3}
----------------------------

The authors declare the following conflict of interests: Charles H. Crawford III: is an employee of Norton Healthcare; received consulting fees from Alphatec, Medtronic and Nuvasive; received payments for speaking from Medtronic and Titan; received funds for trips and travel from SRS and NASS and is on the scientific board of Medtronic. Roger K. Owens II: is an employee of Norton Healthcare; receives consulting fees from Medtronic, Alphatec and Nuvasive; funds for trips and travel from DePuy, Sunthes. Mladen Djurasovic: is an employee of Norton Healthcare; receives consulting fees from Medtronic and Nuvasive, Jeffrey L. Gum: receives royalties from Acuity; receives consulting fees from Medtronic, DePuy, Alphatec, Stryker, Acuity, K2M, Nuvasuve, PacMed; receives honoraria from Pacira; John R. Dimar II: is an employee of Norton Healthcare; receives royalties, consulting and speaker fees from Medtronic, Member of Board of Directors of the Scoliosis Research Society Leah Y. Carreon: is an employee of Norton Healthcare; Member, Editorial Advisory Board, Spine Deformity, Spine and Spine Journal; Institutional Review Board Member, University of Louisville.

Additional information {#sec5.4}
----------------------

No additional information is available for this paper.

[^1]: ODI = Oswestry Disability Index (0--100), BP = Back pain (0--10), LP = Leg pain (0--10), EQ5D = EuroQol-5D (0--1).

[^2]: NS = No Significant difference, NR = Not Reported, \* = Favors open.
